Plus: Myanmar Molecular seeks Health Canada approval. The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using this form to ensure you don’t miss out on the most important healthtech news every week! Big Pharma’s research spending in Canada declined in 2022, despite federal push Despite the federal government’s major pandemic-driven investments in rebuilding Canada’s pharmaceutical industry, drug companies spent less on research in Canada in 2022 than they did the year before. The industry says Canada needs more coordinated policy and “reasonable, predictable and stable” price regulations to make pharma companies really
Hence then, the article about h t the healthtech times canadian pharmaceutical research spending dropped in 2022 was published today ( ) and is available oncanadian news today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( H|T: The Healthtech Times – Canadian pharmaceutical research spending dropped in 2022 )